A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells

Related articles

1. CellCage™ Technology Enables High-throughput Isolation of Defined Cell Combinations to Resolve the Determinants of CAR-T mediated Cytotoxicity

   This article has 16 authors:

   1. Richard G Yau
   2. Shreya Deshmukh
   3. Makenzie Sacca
   4. Ria Gupta
   5. Yanping Yang
   6. Mehdi Mohseni
   7. Liz Y Wu
   8. Filiz Gorpe Yasar
   9. Shan Sabri
   10. Teresa Ai
   11. Tarun K Khurana
   12. Shawn Levy
   13. Pier Federico Gherardini
   14. Christopher Mason
   15. Moonsoo M. Jin
   16. Gary P Schroth

2. A Lymphomimetic Synthetic Immune Niche, Consisting of CCL21 and ICAM1, Accelerates the Expansion of Potent CAR T-cells

   This article has 5 authors:

   1. Karin Brezinger-Dayan
   2. Sofi Yado
   3. Rawan Zoabi
   4. Benjamin Geiger
   5. Michal J Besser

3. Protein design to broadly reprogram engineered T cell function

   This article has 20 authors:

   1. Scott E. Boyken
   2. Sean Merillat
   3. Robert A. Langan
   4. Howell F. Moffett
   5. Brian Coventry
   6. Françoise Haeseleer
   7. Kevin G. Haworth
   8. Inna Goreshnik
   9. Joseph DeSautelle
   10. John Chukinas
   11. Bradley Hammerson
   12. Thaddeus M. Davenport
   13. Duy Nguyen
   14. Rupesh Amin
   15. Shujun Yuan
   16. Glenna Wink Foight
   17. Brian D. Weitzner
   18. Aaron E. Foster
   19. David Baker
   20. Marc J. Lajoie